All Posts Tagged With: "BIOS"
(BIOS) BioScrip Analyst Maintains Neutral Rating on Shares
We maintain our Neutral recommendation on BioScrip Inc. (BIOS) with a target price of $6.25.
BioScrip reported a loss of 4 cents per share in the second quarter of fiscal 2011 compared with the year-ago...
(BIOS) BioScrip Pharmacy Accredited
BioScrip Inc. (BIOS), a health care-related company recently received accreditation for its specialty pharmacy and mail service pharmacy from Utilization Review Accreditation Commission (URAC), a Washington-based...
(BIOS) BioScrip Analyst Reaffirms Shares at Neutral
We maintain our Neutral recommendation on BioScrip Inc. (BIOS) following its tepid third-quarter fiscal 2010 results. Earnings for the quarter trailed both the Zacks Consensus Estimate and the year-ago earnings....
(HUM) June 2010 – Industry Outlook – Health Care Stock Review
The health care sector comprises different industries, ranging from managed care organizations, healthcare facilities providers and medical devices manufacturers to biotech and pharmaceutical companies. Consequently, we believe that investors in this sector should be mindful...
(WLP) Health Care Outlook & Stock Review – Industry Outlook
OVERVIEW
The healthcare sector comprises different industries, ranging from managed care organizations, healthcare facilities providers and medical devices manufacturers to biotech and pharmaceutical companies. Consequently, we believe that investors...
(BIOS) BioScrip’s Fourth Quarter Report Shows Revenue Slide
BioScrip Inc. (BIOS) reported fourth-quarter earnings of 99 cents per share Incorporatedluding the impact of items such as the reversal of deferred tax valuation allowance of $41.1 million, expenses of $1.8...
(UNH) Healthcare Stock Review – December 2009 – Industry Outlook
OVERVIEW
The healthcare sector comprises different industries, ranging from managed care organizations, healthcare facilities providers and medical devices manufacturers to biotech and pharmaceutical companies. Consequently, we believe that investors...
(ALLI) Allion Healthcare Beats Estimates by a Penny
Allion Healthcare (ALLI) reported third quarter earnings of 13 cents per share excluding expenses related to the merger with an affiliate of H.I.G. Capital, LLC, beating the Zacks Consensus Estimate by a...
(BIOS) BioScrip Earnings Report Beats Forecasts in Q3
BioScrip, Inc. (BIOS) reported third-quarter earnings of 14 cents per share, beating the Zacks Consensus Estimate of 10 cents. The company reported earnings of 6 cents in the year-ago period. Although earnings...
(ALLI) Allion Healthcare to be Acquired by H.I.G. Capital
Recently, Allion Healthcare Inc. (ALLI) inked a deal with an affiliate of H.I.G. Capital, LLC, a leading global private investment firm, whereby it agreed to be acquired by the private company. The deal is worth approximately...
(BIOS) Healthcare Industry – Industry Outlook
Investor sentiment in healthcare continues to be driven by both Washington and the state of the broader economy.
In late February, President Obama released his administration’s first budget proposal, which included the provision of a $630B reserve fund for healthcare...